Developed for Pfizer

Access Patients in Their Communities

Hawthorne Health is a community-based site network designed to support enrollment, retention, and execution.

Access changes everything.

Hawthorne Health is a pharmacy-based site network designed to support sponsors, like Pfizer, seeking to expand patient access through community-based clinical research across dermatology, neurology, respiratory, vaccine, and cardio-metabolic studies.

Our model engages patients through trusted healthcare settings, including clinics, pharmacies, and affiliated community care locations across the United States. Centralized operational oversight and standardized workflows support protocol-compliant execution while helping reduce barriers to participation and retention.

Community Trial Solutions

Connecting Pfizer to community-based care environments patients already utilize every day.

Benefits to Partnering with Hawthorne Health:

  • Eliminate patient barriers

  • Drive greater enrollment

  • Increase retention

  • Improve study compliance

Pharmacy-Based Site Network

Built to reach patients traditionally excluded from existing research models, Hawthorne Health brings clinical trials to the heart of communities through a nationwide network of pharmacy-based sites.

Familiar settings and convenient locations help to reduce barriers to participation while improving patient retention and study outcomes.

Proposed Network Overview

We have identified a set of community-based sites and investigators aligned to support your pipeline, selected based on:

  • Existing patient flow within relevant populations

  • Established care relationships in local communities

  • Geographic distribution to support enrollment coverage

  • Ability to support both site-based and lower-burden visit structures

Hawthorne Site Demographics

Dermatology

Hawthorne Health supports dermatology studies through community-based investigators with experience serving diverse patient populations across established outpatient care settings.

Neurology

Our neurology capabilities are designed to support patient recruitment and retention through trusted local care relationships and geographically distributed investigator coverage.

Respiratory

Hawthorne’s respiratory capabilities combine community-based access with operational flexibility designed to support studies involving asthma, allergy, pulmonary, and chronic respiratory populations.

Vaccine

Hawthorne supports vaccine studies through community-based sites positioned to engage broad patient populations across multiple regions.

Cardio-Metabolic

Hawthorne supports cardio-metabolic research through investigators serving patients across cardiology, endocrine, obesity, and chronic disease populations.

Operational Model

One operational partner across sites and homes.

Hawthorne’s operating model is designed to simplify study execution across community sites and in-home settings through centralized governance and standardized processes.

Capabilities include:

  • One CTA across participating community sites

  • Centralized feasibility and startup oversight

  • Standardized workflows and reporting

  • One project management structure across visit locations

  • Nationwide in-home support capabilities

  • 2,000+ GCP-trained clinicians

  • Coverage across all 50 U.S. states

  • 60,000+ completed at-home study visits

Salima Eljaiek-Justino

Director, BD

Salima brings more than 15 years of experience across clinical trial operations, decentralized research delivery, patient-centric services, and business development. As Director of Business Development at Hawthorne Health, she works with sponsors and CROs to support community-based and hybrid clinical trial strategies designed to improve patient access, operational flexibility, and study execution.

Prior to joining Hawthorne, Salima held leadership and operational roles at ICON/Accellacare, Marken, Firma Clinical Research, LabCorp Clinical Trials, and Atlantic Health System. Her experience spans project management, home visit operations, patient-centric trial services, and decentralized clinical trial delivery across a broad range of therapeutic areas and study models.